Login

Julien Guerrand of TCM Capital and Martin Baumann, Co-Founder of CMCC Global, share insights as hedge fund and capital management leaders. 00:10:00

Share On Facebook Share On Twitter

Julien Guerrand of TCM Capital

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
CEO Discusses Strong Quarterly Report and Share Buyback Program Announcement | Per-Erik Eriksson , CEO, Arise AB.
00:10:00
4GLOBAL focused on transition after "very good" 2022 | Eloy Mazon, CEO, 4Global PLC4GBL:LSE
00:00:00
Brian Murphy Chief Executive Officer and Director, NanoVibronix Inc
00:10:00
Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings
00:10:00
Marine In Depth - Electronic Logbooks with Cesare D'Apì | Paolo d'Amico, CEO, d'Amico International Shipping SADIS:MIL
00:10:00
Listen, strategize, and support our partners as we pursue our shared goals.|Jeffrey Ansell, Strategic Executive Advisor,Vestar Capital Partners
00:10:00
Dr. Robert Thomann, Innovationsmanager der MVV Energie AG, spricht über die Bedeutung von Innovationen für die Energiebranche.
00:10:00
Innovative Strategies for Impactful Charitable Giving | Nick Stonestreet, CEO at Ronald Blue Trust
00:10:00
Key Insights from Wol Kolade's Success Talks Q&A Session | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
Redefining Financial Advisory: Beyond Numbers and Investments
00:10:00
Miki leads Doosan Corporation's strategy and serves as CEO of Doosan Tesna, focusing on enhancing their semiconductor business and advancing technological innovations​ |Jong-Do Lee is Chairman & Chief Executive Officer at TESNA Inc
00:10:00
Paul Glass on NEXION Group's Game-Changing Products and Upcoming ASX Listing | Paul Glass , CEO ,NEXION Group.

© 2026 Nehu